A new method is presented for the determination of 11-nor-A% tetrahydrocannabinol-9-carboxylic acid (THC-9-COOH)in urinebased standard reference materials (SRMs) for marijuana metabolite. This method is based on isotope-dilution liquid chromatography-mass spectrometry (LC-MS) using electrospray for ionization (ESI). An isotopically labeled compound, 5',11-nor-A% THC-9-carboxylic acid-d3, was used as an internal standard. Solidphase extraction (SPE) was used to prepare samples for LC-MS analyses. LC was performed on a C18 column with an isocratic mobile phase consisting of 0.05M of ammonium acetate in methanol/water (75:25). Electrospray ionization in the negative ion mode was used to monitor the [M-H]-ions at m/z 343 and 346 for THC-9-COOH and its labeled internal standard, respectively. Samples of SRM 1507b (THC-9-COOH in freeze-dried urine) were prepared and measured on three separate sets. The within-set coefficients of variation ranged from 0.32% to 2.77%. The correlation coefficients of the regression lines were 0.999 to 1.000. The detection limit for THC-9-COOH with this method is estimated to be 5 pg/mL. This method compared well with the gas chromatography-mass spectrometry method used for certification, and results were within the certified values of THC-9-COOH for SRM 1507b.
Introduction
The growth of illegal drug use has stimulated widespread testing for substance abuse. In an effort to provide reliable standards for the drug-testing community to validate the accuracy of their testing methods, the U.8. National Institute of Standards and Technology (NIST), in cooperation with the College of American Pathologists (CAP), has developed and certified urinebased standard reference materials (SRM) for 11-nor-Ag-tetrahydrocannabinol-9-carboxylic acid (THC-9-COOH)(SRM 1507)(1), cocaine metabolite (SRM 1508) (2), morphine and codeine (SRM 2381) (3), morphine glucuronide (SRM 2382) (4), CAP reference materials for amphetamines (5) and phencyclidine (6) , and multidrugs of abuse (SRM 1511). Most of these SRMs are multilevel materials with one level near the National Institute on Drug Abuse (NIDA) specified cutoff level (7) and two other levels. Certification measurements performed at NIST involve two independent methods for each analyte, which include a different sample preparation procedure, a different form of chromatography, and a different means of detection. One of the two methods typically uses gas chromatography-mass spectrometry (GC-MS), and the other is usually a reversed-phase liquid chromatography (LC) method with either MS or UV detection. Agreement among these methods minimizes the likelihood of undetected bias.
GC-MS is the most commonly used method to positively identify and quantitate drugs and their metabolites in urine, and it was employed as the primary method for the determination of all the drugs-of-abuse in urine SRMs (1) (2) (3) (4) (5) (6) . A variety of methods have been reported for the determination of THC-9-COOH in biological samples using GC-MS (1, (8) (9) (10) (11) (12) . The first method used to certify SRM 1507b, the principal urinary metabolite of marijuana (THC-9-COOH), was the GC-MS procedure (1) developed at NIST for the first THC-9-COOH SRM (1507) except that a different SPE column was used. This method uses SPE to isolate the THC-9-COOH from the urine, followed by isotope-dilution GC-MS for measurement. Good precision, sensitivity, and linearity were obtained from the GC-MS method.
The second method used for all the drugs-of-abuse SRMs except THC-9-COOH, involved an LC-MS method with thermospray ionization. LC-MS provides an independent means of ionization and because no derivatization of the analyte is necessary (in contrast to the usual situation with GC-MS), both method development and sample preparation can be considerably shortened. The thermospray instrument provides sufficient selectivity and sensitivity for most drugs at their cutoff levels specified by NIDA. The cutoff level for THC-9-COOH (15 ng/mL) is much lower than for other drugs. Attempts were made to use an LC-MS-thermospray approach for THC-9-COOH, but adequate sensitivity could not be achieved. Instead, LC with UV detection was chosen as a second method. The problems encountered with the LC-UV method were limited selectivity and sensitivity. Considerable efforts were focused on developing a very specific gradient system to carefully separate THC-9-COOH from urine matrix interferences. Precision of the LC-UV method was not quite satisfactory with coefficients of variation (CVs) ranging from 3.5% to 10.6%. Results of THC-9-COOH in SRM 1507b from the GC-MS and LC-UV methods did not agree within acceptable limits. Therefore, a third method involving GC and a different mass spectrometry approach, tandem mass spectrometry (MS-MS), was used to help resolve the discrepancy.
Recent developments of highly sensitive LC-MS instruments with robust interfaces such as electrospray or atmospheric pressure chemical ionization (APCI), make it possible to develop highly precise, selective, and sensitive LC-MS methods for low level analytes. We have developed a new isotope-dilution LC-MS-ESI method for the determination of THC-9-COOH in urinebased SRMs. This new LC-MS-ESI method was evaluated by measuring THC-9-COOH in SRM 1507b that had been certified in 1993 using results from GC-MS, LC-UV, and GC-MS--MS measurements and was further analyzed four additional times by GC-MS for stability checks. The results of measurements using LC-MS-ESI were compared with the previous GC-MS results and the certified values for this SRM.
Experimental
Materials THC-9-COOH reference compound and an ethanolic solution of the isotopically labeled internal standard, 5',11-nor-Ag-THC-9-carboxylic acid-d3 (THC-9-COOH-d3), were obtained from Research Triangle Institute (Research Triangle Park, NC). The impurities of THC-9-COOH reference compound were evaluated at NIST by direct probe MS and GC-MS. The total impurities were determined to be less than 1%. Therefore, no corrections were made for purity.
C18 Sep-Pak solid-phase extraction cartridges were obtained from Waters Associates (Milford, MA). A Zorbax Eclipse XDB-C18 column (15 cm x 2.1-mm i.d., 5-]Jm particle size) was obtained 
Sample preparation
Samples of SRM 1507b were prepared in three different sets, each set consisting of two vials each of the three levels (1, 2, and 3). The vials were reconstituted with 20.0 mL of distilled water and allowed to stand for 30 rain with occasional swirling to ensure complete dissolution. Duplicate 8.0-mL aliquots were taken from each vial for levels 1 and 2, and duplicate 5.0-mE aliquots were taken for leve] 3. Each aliquot was then spiked with an appropriate amount of a stable isotopically labeled internal standard, THC-9-COOH-d3, at a concentration of 2 pg/mL of anhydrous ethanol to give approximately 1:1 ratio of analyte to internal standard. C18 Sep-Pak cartridges were used to isolate the THC-9-COOH from the urine (1). The urine samples were acidified to pH 3-4 by adding an appropriate amount of glacial acetic acid. Each sample was loaded at a rate of 3 to 4 mL/min onto a cartridge previously conditioned by wetting with 3 mL of methanol followed by 5 mL of water. The cartridge was then washed with 5 mL of water followed by 5 mL of acetonitrile/water (40:60). The THC-9-COOH was eluted from the cartridge with 3 mL of methanol. The eluent was dried under nitrogen at 40~ and reconstituted with 200 pL of the mobile phase consisting of 50raM ammonium acetate in methanol/water (75:25) for level 1, 400 pL for level 2, and 500 ]aL for level 3 for the LC-MS analysis. Two vials of blank urine were also prepared in a separate set.
LC-MS electrospray analysis
Standard solutions of THC-9-COOH were prepared as follows. Two unlabeled THC-9-COOH stock solutions at concentrations of approximately 2 pg/mL in anhydrous ethanol were prepared. These two standard stock solutions were cross-checked against each other. They were in very good agreement (within 0.5%). Four aliquots from one stock were spiked with the labeled internal standard yielding four standards with the mass ratios of unlabeled to labeled compound ranging from 0.6993 to 1.2933. The mixtures were dried and reconstituted with the mobile phase for LC-MS measurement.
Analysis was performed on a Hewlett-Packard 1100 series LC-MSD with an electrospray ionization interface. An autosampier was used. Aliquots of 20 pL of standard or sample extract (approximately 10 ng of THC-9-COOH) were separated by LC on a Zorbax Eclipse XDB-C18 column with an isocratic mobile phase consisting of 0.05M of ammonium acetate in methanol/water (75:25). The flow rate was 0.3 mlJmin. Electrospray ionization in the negative ion mode was used to monitor the [M-H]-ions at m/z 343 and 346 for THC-9-COOH and its labeled internal standard, respectively. Drying gas temperature was set at 350~ and flow at 12 L/min. Nebulizer pressure was set at 25 psi, fragmentor at 90 V, and Vcap at 3500 V. The following measurement protocol was used for the LC-MS analyses. For each level of samples, a single analysis of each of the four standards was run first. Subsequently, duplicate analyses of each sample were run. Finally, the four standards were run again in reverse order. By combining the data of standards run before and after the samples, a composite linear regression was calculated, which was used to convert the measured intensity ratios of analyte to mass ratios. The mass ratios were then used along with the amounts of the internal standard added to calculate analyte concentrations.
Results and Discussion
The results of LC-MS-ESI measurements of THC-9-COOH in SRM 1507b are shown in Tables I-III. Excellent precision was obtained for all three levels with within-set CVs ranging from 0.5% to 2.8%. Excellent linearity was also obtained with the correlation coefficients of all linear regression lines ranging from 0.999 to 1.000. The detection limit at a signal-to-noise ratio of approximately 3 to 5 for THC-9-COOH with this method is estimated to be 5 pg/mL. No THC-9-COOH was detected in the blank urine sample. Single ion chromatograms for both a standard and a sample of SRM 1507b are shown in Figures 1 and 2, respectively.
An analysis of variance on the combined data from the three levels showed that set-set differences were significant (p = 0.003). This is frequently the situation when within-set precision is very good. Therefore, the set means for each level were used to calculate standard deviations and degrees of freedom. Combining the measurement uncertainty with the uncertainty in the purity of the reference compound (type B uncertainty) and multiplying by a coverage factor based upon the degrees of freedom yielded the expanded uncertainties shown in Table IV . These uncertainties represent a 95% confidence level for each level. The precision, sensitivity, and linearity of this LC-MS-ESI method for THC-9-COOH were excel-lent, and they were comparable to the GC-MS method. This LC-MS-ESI method involved a different sample preparation procedure, a different form of chromatography, and a different means of detection without derivatization and can be used as a reliable independent method for the measurement of THC-9-COOH.
Conclusions
A simple, reliable, and sensitive method based on isotope-dilution LC-MS with electrospray ionization was developed for the determination of THC-9-COOH in a urine-based SRM. This method compares well with the GC-MS method used for certification, and can be used as an independent method for the measurement of THC-9-COOH.
